(Q39897898)

English

LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Mayumi Komachi

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hideaki Tomura

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Enkhzol Malchinkhuu

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Masayuki Tobo

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Chihiro Mogi

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Takayuki Yamada

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Takao Kimura

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Atsushi Kuwabara

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hideo Ohta

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Doon-Soon Im

10

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hitoshi Kurose

11

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Izumi Takeyoshi

12

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Koichi Sato

13

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Fumikazu Okajima

14

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

7 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

457-465

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Development of gene therapy to target pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Invasion and metastasis in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophospholipid receptors: signaling and biology

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Biological roles of lysophospholipid receptors revealed by genetic null mice: an update

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Tumor necrosis factor- induces adhesion molecule expression through the sphingosine kinase pathway

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

The emerging role of lysophosphatidic acid in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

The ins and outs of lysophosphatidic acid signaling.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophosphatidic acid receptor-selective effects on Jurkat T cell migration through a Matrigel model basement membrane

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Cyclooxygenase-2 expression and prostaglandin E2 production in response to acidic pH through OGR1 in a human osteoblastic cell line

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Gα12 and Gα13 as key regulatory mediator in signal transduction

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Rho-dependent, Rho kinase-independent inhibitory regulation of Rac and cell migration by LPA1 receptor in Gi-inactivated CHO cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Rho family proteins in cell adhesion and cell migration.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Cell migration: Rho GTPases lead the way

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

PTEN as an effector in the signaling of antimigratory G protein-coupled receptor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Cyclin D1 functions in cell migration

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Inhibition of Rho-kinase affects astrocytoma morphology, motility, and invasion through activation of Rac1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Role of the monomeric GTPase Rho in hematopoietic progenitor cell migration and transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGP011

21 January 2018

Identifiers

10.1093/CARCIN/BGP011

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39897898&oldid=2092313382"